FYN and multiple sclerosis: Whether or not Fyn contributes to the severity of diseases in which myelin growth or structure is damaged, such as multiple sclerosis (MS) or ischemic and traumatic brain injury [83], or neuropsychiatric diseases such as schizophrenia [84] or neurodegenerative diseases, such as Alzheimer’s disease [85,86] is largely controverted.